JY
CTSO icon

Jeff Yass’s Cytosorbents Corp CTSO Stock Holding History

Jeff Yass’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,100
Closed -$50.9K – 12209
2023
Q1 		$50.9K Buy
+15,100
New +$45.3K ﹤0.01% 11696
2022
Q3 		– Sell
-26,000
Closed -$57K – 13290
2022
Q2 		$57K Buy
26,000
+3,900
+18% +$8.95K ﹤0.01% 11893
2022
Q1 		$70K Buy
+22,100
New +$79.2K ﹤0.01% 12129
2021
Q4 		– Sell
-30,500
Closed -$248K – 13196
2021
Q3 		$248K Buy
30,500
+5,200
+21% +$42.2K ﹤0.01% 11025
2021
Q2 		$191K Sell
25,300
-26,700
-51% -$225K ﹤0.01% 11641
2021
Q1 		$451K Buy
52,000
+18,700
+56% +$178K ﹤0.01% 9713
2020
Q4 		$265K Buy
33,300
+10,600
+47% +$88.7K ﹤0.01% 9529
2020
Q3 		$181K Sell
22,700
-83,600
-79% -$754K ﹤0.01% 9537
2020
Q2 		$1.05M Buy
106,300
+70,300
+195% +$646K ﹤0.01% 5807
2020
Q1 		$278K Buy
+36,000
New +$182K ﹤0.01% 8124
2018
Q4 		– Sell
-27,300
Closed -$352K – 9062
2018
Q3 		$352K Sell
27,300
-17,800
-39% -$223K ﹤0.01% 7156
2018
Q2 		$514K Sell
45,100
-35,500
-44% -$336K ﹤0.01% 6724
2018
Q1 		$568K Buy
80,600
+35,500
+79% +$268K ﹤0.01% 6369
2017
Q4 		$293K Buy
+45,100
New +$287K ﹤0.01% 7632
2017
Q3 		– Sell
-15,300
Closed -$66K – 8912
2017
Q2 		$66K Sell
15,300
-7,700
-33% -$33.8K ﹤0.01% 8830
2017
Q1 		$104K Buy
23,000
+6,800
+42% +$38K ﹤0.01% 8367
2016
Q4 		$88K Sell
16,200
-35,800
-69% -$196K ﹤0.01% 9132
2016
Q3 		$333K Buy
52,000
+21,900
+73% +$114K ﹤0.01% 6760
2016
Q2 		$137K Sell
30,100
-11,400
-27% -$49.6K ﹤0.01% 7866
2016
Q1 		$163K Sell
41,500
-78,900
-66% -$342K ﹤0.01% 8147
2015
Q4 		$671K Buy
120,400
+48,300
+67% +$329K ﹤0.01% 6225
2015
Q3 		$455K Sell
72,100
-12,000
-14% -$80K ﹤0.01% 7302
2015
Q2 		$520K Buy
+84,100
New +$572K ﹤0.01% 7566

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jeff Yass's CTSO Position: Q2 2026 in Review

Jeff Yass sold out of Cytosorbents Corp (CTSO) in Q2 2026, closing a stake of 29,945 shares — an estimated $17K sold.

Jeff Yass first reported a position in CTSO in Q1 2015 and held it in 36 quarters. The position peaked at $1.11M in Q3 2017. 51 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • Jeff Yass reported no remaining Cytosorbents Corp position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 29,945 Cytosorbents Corp shares in Q2 2026, an estimated $17K.
  • Jeff Yass first reported a position in Cytosorbents Corp in Q1 2015 and held it in 36 quarters.
  • Jeff Yass's Cytosorbents Corp position peaked at $1.11M in Q3 2017.
  • 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.